@article{4d810eb83d4e46099476da8627eb227c,
title = "Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group",
keywords = "allogeneic stem cell transplant, AML, induction chemotherapy, long-term follow-up, measurable residual disease, nationwide, randomized, survival, YOUNGER PATIENTS, CLASSIFICATION, CHEMOTHERAPY, ADULTS, STANDARD, THERAPY, 3122 Cancers",
author = "{Finnish Leukemia Group} and Aarne Kolonen and Marjatta Sinisalo and Heini Huhtala and Johanna Rimpil{\"a}inen and Hannele Rintala and Marja Sankelo and Elli Koivunen and Raija Silvennoinen and Riikka R{\"a}ty and Tapani Ruutu and Liisa Volin and Kimmo Porkka and Esa Jantunen and Tapio Nousiainen and Taru Kuittinen and Karri Penttil{\"a} and Marja Py{\"o}r{\"a}l{\"a} and Marjaana S{\"a}ily and Pirjo Koistinen and Marjut Kauppila and Maija It{\"a}l{\"a}-Remes and Hanna Ollikainen and Auvo Rauhala and Veli Kairisto and Tarja-Terttu Pelliniemi and Erkki Elonen",
year = "2022",
month = sep,
doi = "10.1111/ejh.13805",
language = "English",
volume = "109",
pages = "257--270",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley",
number = "3",
}